Evidence map›Paper›PMID 28778186›Full record

ArticleBMC infectious diseases2017

Preservation of sputum samples with cetylpyridinium chloride (CPC) for tuberculosis cultures and Xpert MTB/RIF in a low-income country.

Hellen Hiza, Basra Doulla, Mohamed Sasamalo, Jerry Hella, Lujeko Kamwela, Francis Mhimbira, Klaus Reither, Sebastien Gagneux, Levan Jugheli, Lukas Fenner

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hellen HizaIfakara Health Institute, Bagamoyo, Tanzania.
Basra DoullaNational Tuberculosis and Leprosy Programme, Dar es Salaam, Tanzania.
Mohamed SasamaloIfakara Health Institute, Bagamoyo, Tanzania.
Jerry HellaIfakara Health Institute, Bagamoyo, Tanzania.
Lujeko KamwelaIfakara Health Institute, Bagamoyo, Tanzania.
Francis MhimbiraIfakara Health Institute, Bagamoyo, Tanzania.
Klaus ReitherIfakara Health Institute, Bagamoyo, Tanzania.
Sebastien GagneuxSwiss Tropical and Public Health Institute, Basel, Switzerland.
Levan JugheliIfakara Health Institute, Bagamoyo, Tanzania.
Lukas FennerIfakara Health Institute, Bagamoyo, Tanzania. lukas.fenner@ispm.unibe.ch.
University of Basel · CHIfakara Health Institute · TZSwiss Tropical and Public Health Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCulture contamination with environmental bacteria is a major challenge in tuberculosis (TB) laboratories in hot and humid climate zones. We studied the effect of cetylpyridinium chloride (CPC) preservation on culture results and performance of Xpert MTB/RIF.

methodsConsecutive sputum samples from microscopy smear-positive TB patients were collected. Two-hundred samples were equally split in two aliquots, one aliquot was treated with CPC and stored at ambient temperature for 7 days. The second aliquot was immediately processed. Samples were decontaminated for 20, 15 or 10 min, and subsequently cultured on Löwenstein-Jensen medium. Furthermore, 50 samples were stored for 7, 14 and 21 days, and 100 CPC-pretreated samples tested by Xpert MTB/RIF.

resultsCPC pretreated samples showed a higher culture yield compared to non-treated sputum samples across all decontamination times: 94% vs. 73% at 10 min (p = 0.01), 94% vs. 64% at 15 min (p = 0.004), and 90% vs. 52% at 20 min (p < 0.001). The quantitative culture grading was consistently higher in CPC treated compared to non-CPC treated samples. The proportion of contaminated cultures was lower in CPC pretreated samples across all decontamination times (range 2-6%) compared to non-CPC treated samples (15-16%). For storage times of CPC treated samples of 7, 14, and 21 days, 84, 86, and 84% of the respective cultures were positive. Of 91 CPC treated samples with a positive culture, 90 were also Xpert MTB/RIF positive.

conclusionsCPC increases culture yield, decreases the proportion of contamination, and does not alter the performance of Xpert MTB/RIF.

Indexed as

Bacteriological TechniquesCetylpyridiniumDeveloping CountriesHumansMicroscopyMycobacterium tuberculosisNucleic Acid Amplification TechniquesSpecimen HandlingSputumTanzaniaTuberculosis, PulmonaryCetylpyridiniumCetylpyridinium chlorideContaminationCPCCultureLow-income countryMycobacterium tuberculosisPreservationRecoverySample transportSputumTuberculosis

Identifiers

PMID28778186
PMCPMC5543576
OpenAlexW2745138104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.